These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 473479)

  • 21. Treatment of cyclophosphamide induced hemorrhagic cystitis with neodymium:YAG laser in pediatric patients.
    Gweon P; Shanberg A
    J Urol; 1997 Jun; 157(6):2301-2. PubMed ID: 9146658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide-induced hemorrhagic cystitis in Ewing's sarcoma.
    Stillwell TJ; Benson RC; Burgert EO
    J Clin Oncol; 1988 Jan; 6(1):76-82. PubMed ID: 3335893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.
    Turkeri LN; Lum LG; Uberti JP; Abella E; Momin F; Karanes C; Sensenbrenner LL; Haas GP
    J Urol; 1995 Mar; 153(3 Pt 1):637-40. PubMed ID: 7861502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclophosphamide cystitis with bladder wall calcification.
    Francis RS; Shackelford GD
    J Can Assoc Radiol; 1974 Dec; 25(4):324-6. PubMed ID: 4531432
    [No Abstract]   [Full Text] [Related]  

  • 25. Cutaneous and other complications of cyclophosphamide: a brief review.
    Jessen RT; Straight M; Smith EB
    Rocky Mt Med J; 1978; 75(4):204-6. PubMed ID: 684340
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral bolus cyclophosphamide--liberating libation or nauseating nostrum?
    McCune WJ
    J Rheumatol; 1996 Feb; 23(2):212-3. PubMed ID: 8882020
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy.
    Gray KJ; Engelmann UH; Johnson EH; Fishman IJ
    J Urol; 1986 Aug; 136(2):497-500. PubMed ID: 3090278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cylophosphamide (CPA)-induced bladder toxicity by N-acetylcysteine (NAC) in rats.
    Harris E; Levy L; Levy J
    Proc West Pharmacol Soc; 1975; 18():354-7. PubMed ID: 1178695
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy.
    Johnson WW; Meadows DC
    N Engl J Med; 1971 Feb; 284(6):290-4. PubMed ID: 4321778
    [No Abstract]   [Full Text] [Related]  

  • 30. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa.
    Treible DP; Skinner D; Kasimain D; Friedman NB; Kern WH
    Urology; 1987 Dec; 30(6):568-70. PubMed ID: 3120389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hemorrhagic diathesis with involvement of hypothalamus produced in rats by cyclophosphamide.
    Levine S; Sowinski R
    Am J Pathol; 1974 Jan; 74(1):171-7. PubMed ID: 4543722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncontrollable hemorrhage secondary to bladder carcinoma and cyclophosphamide cystitis. Mount Sinai Hospital experience with intravesical formalin instillation.
    Stein M; Leiter E
    N Y State J Med; 1978 Jun; 78(7):1056-8. PubMed ID: 275611
    [No Abstract]   [Full Text] [Related]  

  • 33. Busulfan-induced hemorrhagic cystitis.
    Pode D; Perlberg S; Steiner D
    J Urol; 1983 Aug; 130(2):347-8. PubMed ID: 6576177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced bladder and urinary disorders. Incidence, prevention and management.
    Drake MJ; Nixon PM; Crew JP
    Drug Saf; 1998 Jul; 19(1):45-55. PubMed ID: 9673857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of effects of chitosan in preventing hemorrhagic cystitis in rats induced by cyclophosphamide.
    Okamura T; Masui T; St John MK; Cohen SM; Taylor RJ
    Hinyokika Kiyo; 1995 Apr; 41(4):289-96. PubMed ID: 7785558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On mucosal denudation of the urinary bladder contracted due to inflammation induced by a corrosive agent.
    Morimoto Y
    Osaka City Med J; 1967; 13(1):55-73. PubMed ID: 6076944
    [No Abstract]   [Full Text] [Related]  

  • 37. RE: Urological complications of cyclophosphamide.
    Schootstra R
    J Urol; 1990 Jun; 143(6):1237. PubMed ID: 2378645
    [No Abstract]   [Full Text] [Related]  

  • 38. Errors and pitfalls in cytology of the lower urinary tract.
    Koss LG
    Monogr Pathol; 1997; (39):60-74. PubMed ID: 9249820
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ; McCune WJ
    N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclophosphamide in the treatment of the nephrotic syndrome in childhood.
    Spitzer A
    Pediatrics; 1972 Sep; 50(3):358-60. PubMed ID: 5056408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.